1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer : Results from the phase 3 PANTHER trial
(
- Contribution to journal › Article
- 2016
-
Mark
Societal cost of subcutaneous and intravenous trastuzumab for HER2-positive breast cancer – An observational study prospectively recording resource utilization in a Swedish healthcare setting
(
- Contribution to journal › Article
- 2015
-
Mark
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling
(
- Contribution to journal › Article
- 2012
-
Mark
Hypoxia changes the expression of the epidermal growth factor (EGF) system in human hearts and cultured cardiomyocytes
(
- Contribution to journal › Article